Exhibit 107
FORM S-1/A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
(Form Type)
QUOIN PHARMACEUTICALS LTD.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title(1) | Fee | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of Registration Fee | Carry | Carry | Carry | Filing Fee |
Newly Registered Securities | ||||||||||||
Fees to be paid | Equity | Ordinary shares, no par value per share (“Ordinary Shares”), represented by American Depositary Shares (“ADSs”)(3) | Rule 457(o) | | | $20,000,000.00 | 0.00011020 | $2,204.00(4) | | | | |
| Other | Pre-Funded Warrants to purchase Ordinary Shares represented by ADSs | Other | | | | | | | | | |
| Other | Common Warrants to purchase Ordinary Shares represented by ADSs | Other | | | | | | | | | |
| | | | | | | | | | | | | |
| Equity | Ordinary Shares represented by ADSs issuable upon the exercise of Pre-Funded Warrants | Other | | | | | | | | | | |
| Equity | Ordinary Shares represented by ADSs issuable upon the exercise of Common Warrants | Other | | | | | | | | | | |
Fees Previously Paid | | | | | | | | — | | | | | |
Carry Forward Securities | |||||||||||||
Carry Forward Securities | | | | | | | | | | | | | |
Total Offering Amounts | $20,000,000.00 | | $2,204.00 | | | | | ||||||
Total Fees Previously Paid | | | $1,102.00 | | | | | ||||||
Total Fee Offsets | | | $0.00 | | | | | ||||||
Net Fee Due | | | $1,102.00 | | | | | ||||||
(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered such additional securities that may be issued because of events such as recapitalizations, stock dividends, stock splits and reverse stock splits, and similar transactions.
(2) Estimated solely for the purpose of determining the amount of the registration fee in accordance with Rule 457(o) under the Securities Act.
(3) American Depositary Shares (“ADSs”) issuable upon deposit of ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (Registration No. 333-212698) filed with the Securities and Exchange Commission. Each ADS represents five thousand (5,000) ordinary shares (“Ordinary Shares”). The proposed maximum aggregate offering price of the Ordinary Shares represented by ADSs proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Warrants offered and sold in the offering (plus the aggregate exercise price of the Ordinary Shares represented by ADSs issuable upon exercise of the Pre-funded Warrants), and as such the proposed aggregate maximum offering price of the Ordinary Shares represented by ADSs and Pre-Funded Warrants (including Ordinary Shares represented by ADSs issuable upon exercise of the Pre-funded Warrants), if any, is $20,000,000.
(4) Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.